# US 2023/0112827 A1 · Bacterial delivery vehicles comprising tracer nucleic acid sequences

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0112827 A1
- Document ID: US20230112827A1
- Status: Published application
- Kind: A1
- Application number: 17/864,757
- Filed: 2022-07-14
- Published: 2023-04-13
- Earliest claimed: 2019-06-18
- Assignees: Eligo Bioscience
- Applicants: Eligo Bioscience
- Inventors: Igor STZEPOURGINSKI; Daniel Garry
- Web page: https://patentgrep.com/patent/US20230112827A1

## CPC

- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 15/74: Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N 15/86: Viral vectors
- C12Q 1/68: involving nucleic acids
- C12Q 1/70: involving virus or bacteriophage {(immunoassay for viruses G01N33/56983)}
- A01K 2207/12: Animals modified by administration of exogenous cells
- A01K 2227/105: Murine
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 2795/10323: Virus like particles [VLP]
- C12N 2795/10342: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
- C12Q 2600/136: Screening for pharmacological compounds
- C12Q 2600/16: Primer sets for multiplex assays
- C40B 20/08: Direct analysis of the library members per se by physical methods, e.g. spectroscopy
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present disclosure relates generally to genetically tagged bacterial delivery vehicles comprising unique tracer nucleic acid sequences (herein referred to as “tracers”) for use in detecting and/or quantitating the presence of two or more different said bacterial delivery vehicles within a mixture of vehicles. The present disclosure relates to methods wherein the bacterial delivery vehicles are detected through, for example, performance of multiple cycles of amplification using primers that bind to sequences within the unique tracer. Such methods can be advantageously used in quality control to detect and quantitate mixtures of bacterial delivery vehicles within a pharmaceutical composition.

## Claims

### Claim 1

A method for detecting and/or quantitating bacterial delivery vehicles, in a multivalent bacterial delivery vehicle mixture wherein each bacterial delivery vehicle comprises a nucleic acid payload with a unique tracer, the method comprising detecting and/or quantitating (i) each bacterial delivery vehicle and/or (ii) in total the bacterial delivery vehicles, through amplification of the tracer using primers that bind to the unique tracer sequence.

### Claim 2 (depends on 1)

The method of claim 1, wherein the unique tracer has a constant region to which primers can bind for initiation of an amplification reaction, and the method comprises detecting and quantitating each bacterial delivery vehicle through amplification of the tracer using primers that bind within the constant region of the tracer sequence.

### Claim 3 (depends on 2)

The method of claim 2, wherein the unique tracer further comprises variable sequences to which primers can bind for amplification and wherein said method further comprises a distinct amplification reaction or a second amplification reaction which uses primer binding to the variable sequences for an amplification method.

### Claim 4 (depends on 1)

The method of claim 1, wherein the unique tracer comprises a variable region to which primers can bind for amplification, and the method comprises detecting and/or quantitating each bacterial delivery vehicle through amplification of the tracer using primers that bind within the variable region of the tracer sequence.

### Claim 5 (depends on 1)

The method of claim 1, wherein each bacterial delivery vehicle comprises a nucleic acid payload with different sequence and a different tracer associated with each different payload.

### Claim 6 (depends on 1)

The method of claim 1, wherein the tracer comprises no more than 20 nucleotides homology stretch with the DNA of the bacterial production strain and/or the DNA of the target bacterial cell.

### Claim 7 (depends on 1)

The method of claim 1, wherein the tracer is selected from one or more of the groups consisting of:
(i) a tracer comprising a barcode;
(ii) a tracer comprising a constant region and a barcode:
(iii) tracer comprising a barcode flanked on each side by a constant region
(iv) a tracer containing a barcode wherein the barcode is between 25 and 50 nucleic acids long;
(v) a tracer containing a constant region wherein the constant region is between 25 and 50 nucleic acids long;
(vi) a tracer embedded in a non-coding region;
(vii) a tracer embedded in a coding region; and
(viii) a tracer embedded in a coding region wherein the tracer comprises altered codon usage while encoding a protein with an unaltered amino acid sequence.

### Claim 8 (depends on 1)

The method of claim 1, wherein detection and/or quantitation of each bacterial delivery vehicle are attained through performance of multiple cycles of amplification using primers that bind to the unique tracer nucleic acid sequence.

### Claim 9 (depends on 1)

The method of claim 1, wherein the bacterial delivery vehicles are bacteriophage derived scaffolds.

### Claim 10 (depends on 9)

The method of claim 9, wherein the bacterial delivery vehicles are bacteriophage derived particles composed of a DNA nucleic acid payload of interest packaged in a bacteriophage-derived capsid.

### Claim 11

A method for detecting and/or quantitating bacterial delivery vehicles in a sample derived from a subject after administration to a subject of a multivalent bacterial delivery vehicle mixture wherein each bacterial delivery vehicle comprises a nucleic acid payload with a unique tracer nucleic acid sequence, the method comprising detecting and/or quantitating (i) each bacterial delivery vehicle and/or (ii) in total the bacterial delivery vehicles, in said sample, through performance of multiple cycles of amplification using primers that bind to the unique tracer sequence.

### Claim 12 (depends on 11)

The method of claim 11, wherein the unique tracer has a constant region to which primers can bind for initiation of an amplification reaction, and the method comprises detecting and/or quantitating each bacterial delivery vehicle through amplification of the tracer using primers that bind within the constant region of the tracer sequence.

### Claim 13 (depends on 12)

The method of claim 12, wherein the unique tracer further comprises variable sequences to which primers can bind for amplification and wherein said method further comprises a distinct amplification reaction or a second amplification reaction which uses primer binding to the variable sequences for an amplification method.

### Claim 14 (depends on 11)

The method of claim 11, wherein the unique tracer comprises a variable region to which primers can bind for amplification, and the method comprises detecting and/or quantitating each bacterial delivery vehicle through amplification of the tracer using primers that bind within the variable region of the tracer sequence.

### Claim 15 (depends on 11)

The method of claim 11, wherein each bacterial delivery vehicle comprises a nucleic acid payload with different sequence and a different tracer associated with each different payload.

### Claim 16 (depends on 11)

The method of claim 11, wherein the tracer comprises no more than 20 nucleotides homology stretch with the DNA of the bacterial production strain and/or the DNA of the target bacterial cell.

### Claim 17 (depends on 11)

The method of claim 11, wherein the tracer is selected from one or more of the groups consisting of:
(i) a tracer comprising a barcode;
(ii) a tracer comprising a constant region and a barcode:
(iii) tracer comprising a barcode flanked on each side by a constant region
(iv) a tracer containing a barcode wherein the barcode is between 25 and 50 nucleic acids long;
(v) a tracer containing a constant region wherein the constant region is between 25 and 50 nucleic acids long;
(vi) a tracer embedded in a non-coding region;
(vii) a tracer embedded in a coding region; and
(viii) a tracer embedded in a coding region wherein the tracer comprises altered codon usage while encoding a protein with an unaltered amino acid sequence.

### Claim 18 (depends on 11)

The method of claim 11, wherein detection and/or quantitation of each bacterial delivery vehicle are attained through performance of multiple cycles of amplification using primers that bind to the unique tracer nucleic acid sequence.

### Claim 19 (depends on 11)

The method of claim 11, wherein the bacterial delivery vehicles are bacteriophage derived scaffolds.

### Claim 20 (depends on 11)

The method of claim 11, wherein the bacterial delivery vehicles are bacteriophage derived particles composed of a DNA nucleic acid payload of interest packaged in a bacteriophage-derived capsid.
